东北制药集团（以下简称东药）是我国制药工业的大型骨干企业之一，由于经营管理不善及市场变化的影响，1996～1997年出现了3亿多元的巨额亏损，生产经营步履维艰，企业陷入困境。1998年，在新领导班子的带领下，东药从危机中奋起，实施了以扭亏脱困为中心的“八大工程”（调产 Northeast Pharmaceutical Group (hereinafter referred to as “Dong Yao”) is one of the large-scale backbone enterprises in the pharmaceutical industry in our country. Due to poor management and market changes, there was a huge loss of more than 300 million yuan from 1996 to 1997, with difficulties in production and operation and enterprises falling into Dilemma. Under the leadership of the new leadership in 1998, the eastern medicine rose from the crisis and implemented the “eight major projects” focusing on turning around deficits and extricating themselves from difficulties